SynopsisThe global Brain Heart Infusion (BHI) Broth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Brain Heart Infusion (BHI) Broth .....
SynopsisThe global Listeria Enrichment Broth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Listeria Enrichment Broth is estimated t.....
SynopsisThe global Amivantamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Amivantamab is estimated to increase from $ million in.....
SynopsisThe global Reagent Grade Teprotumumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Teprotumumab is estimated.....
SynopsisThe global Reagent Grade Epcoritamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Epcoritamab is estimated t.....
SynopsisThe global Reagent Grade Inclacumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Inclacumab is estimated to .....
SynopsisThe global Reagent Grade Teclistamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Teclistamab is estimated t.....
SynopsisThe global Reagent Grade Talquetamab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Talquetamab is estimated t.....
SynopsisThe global Reagent Grade Vixarelimab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Vixarelimab is estimated t.....
SynopsisThe global Reagent Grade Tirnovetmab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Reagent Grade Tirnovetmab is estimated t.....
